University of Maryland study finds median flu vaccine effectiveness 39.5%, below 40%-60% range
A JAMA Network Open analysis found median flu vaccine effectiveness against infection was 39.5%, below the commonly cited 40%-60% range, and the vaccine was often mismatched to circulating strains. The study does not show flu shots are ineffective; it highlights seasonal variability and the limits of a broad effectiveness slogan. For public health messaging, it suggests people should weigh vaccination benefits against imperfect protection.
University of Maryland researchers examined end-of-season estimates of influenza vaccine effectiveness from the 2004-2005 season through 2023-2024, then compared those estimates with how well the season's vaccine matched circulating flu strains. The analysis, published in JAMA Network Open, found a median effectiveness of 39.5% in preventing flu infection, lower than the 40% to 60% range frequently quoted in public guidance.
The team reported that in 11 of the 18 seasons studied, the vaccine was not well matched to the strains that circulated. That matters because higher effectiveness estimates often assume a good match between the vaccine and circulating viruses. The median figure means protection varied widely by season: some years offered more than 39.5% protection against infection, while others offered less.
The findings add nuance to a familiar public health message: flu shots are recommended every year, but their performance can depend on strain matching and the season. The researchers did not argue the vaccine is useless. They said the 40%-60% range may fit some seasons but not all, and that communicating uncertainty should not obscure vaccination's benefits. The CDC estimates flu kills between 6,300 and 52,000 people annually.
For adults and clinicians deciding whether to vaccinate during an early flu season with 2,100 reported deaths so far, the study suggests the expected benefit may be smaller than the 40%-60% slogan implies. It still cites CDC estimates that vaccination saved 7,900 lives and prevented 120,000 hospitalizations and 9.8 million illnesses during 2023-2024. The analysis can show patterns across season estimates, but it cannot explain why effectiveness varied. Researchers said the goal is better vaccines that provide more predictable and lasting protection.
It affects seasonal flu decisions by showing that vaccine protection against infection varies by season and strain match, while CDC estimates still support vaccination as a major tool for preventing illness, hospitalization and death.
Sources (1)
- [1]Original source(https://medicalxpress.com/news/2026-11-flu-vaccine-effectiveness-weaker-advertised.html)